SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — FibroGen Inc. (FGEN) on Monday reported profit of $200.6 million in its third quarter.
On a per-share basis, the San Francisco-based company said it had net income of $49.61. Losses, adjusted for one-time gains and costs, came to $1.61 per share.
The biotech drug developer posted revenue of $1.1 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FGEN at https://www.zacks.com/ap/FGEN
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
